Skip to main content

Gracey Craig's Form 4/A amendment

Amended

Omada Health, Inc. (OMDA) · filed Jul 8, 2026

Accession no.
0001610717-26-000334
Filed
Jul 8, 2026, 8:20 PM ET
Trade date
Jun 26-29, 2026
Filing delay
12 days
Rule 10b5-1 plan
Checked
Original filed
Jun 30, 2026

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $85.4K. It was filed 12 days after the trade.

This amendment replaces 0001610717-26-000307 (filed Jun 30, 2026).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Gracey CraigCIK 0002021724Officer (Chief Accounting Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 26, 2026Common StockMOption exerciseAcquired+2,084$6.57+$13,691.8817,525Direct
Jun 26, 2026Common StockSSaleDisposed−2,084$20.00−$41,68015,441Direct
Jun 29, 2026Common StockMOption exerciseAcquired+2,083$6.57+$13,685.3117,524Direct
Jun 29, 2026Common StockSSaleDisposed−2,083$21.00−$43,74315,441Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 26, 2026Common StockMOption exerciseDisposed−2,084$0.00$037,500Direct
Jun 29, 2026Common StockMOption exerciseDisposed−2,083$0.00$035,417Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

This Form 4/A restates in its entirety the original Form 4 filed on 6/30/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

F2

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

F3

25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read the full filing on SEC EDGAR (opens in a new tab)